|
JP5442449B2
(ja)
|
2006-12-22 |
2014-03-12 |
アステックス、セラピューティックス、リミテッド |
新規化合物
|
|
MX2009006706A
(es)
|
2006-12-22 |
2009-07-02 |
Astex Therapeutics Ltd |
Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
|
|
CN101765585B
(zh)
*
|
2007-06-12 |
2017-03-15 |
尔察祯有限公司 |
抗菌剂
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
|
US20110092554A1
(en)
*
|
2007-11-19 |
2011-04-21 |
Richard Chesworth |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
CA2710477A1
(en)
|
2007-12-20 |
2009-07-09 |
Envivo Pharmaceuticals, Inc. |
Tetrasubstituted benzenes
|
|
US8242145B2
(en)
|
2008-02-14 |
2012-08-14 |
Panmira Pharmaceuticals, Llc |
Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors
|
|
US8426449B2
(en)
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
|
CA2728210A1
(en)
*
|
2008-06-25 |
2009-12-30 |
Schering Corporation |
Synthesis and use of heterocyclic antibacterial agents
|
|
TWI403319B
(zh)
|
2008-07-03 |
2013-08-01 |
Panmira Pharmaceuticals Llc |
前列腺素ｄ2受體之雜烷基拮抗劑
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
WO2010057118A2
(en)
|
2008-11-17 |
2010-05-20 |
Amira Pharmaceuticals, Inc. |
Heterocyclic antagonists of prostaglandin d2 receptors
|
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2011005355A1
(en)
*
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
EP2488502A4
(en)
|
2009-10-16 |
2013-05-15 |
Rib X Pharmaceuticals Inc |
ANTIMICROBIAL COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE
|
|
CA2777739A1
(en)
|
2009-10-16 |
2011-04-21 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
CA2777734A1
(en)
|
2009-10-16 |
2011-04-21 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
KR20120115989A
(ko)
|
2010-01-06 |
2012-10-19 |
판미라 파마슈티칼스, 엘엘씨 |
Ｄｐ2 길항제 및 이의 용도
|
|
NZ603198A
(en)
|
2010-04-20 |
2013-10-25 |
Taisho Pharmaceutical Co Ltd |
Novel hydroxamic acid derivative
|
|
US8835472B2
(en)
*
|
2010-09-02 |
2014-09-16 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
WO2012031298A2
(en)
|
2010-09-03 |
2012-03-08 |
Duke University |
Ethynylbenzene derivatives
|
|
TW201249786A
(en)
*
|
2010-11-10 |
2012-12-16 |
Achaogen Inc |
Antibacterial agents
|
|
SG10201603027QA
(en)
|
2011-04-15 |
2016-05-30 |
Melinta Therapeutics Inc |
Antimicrobial compounds and methods of making and using the same
|
|
UY34305A
(es)
|
2011-09-01 |
2013-04-30 |
Novartis Ag |
Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
|
|
AR087843A1
(es)
|
2011-09-12 |
2014-04-23 |
Achaogen Inc |
Formas polimorficas de n-((s)-3-amino-1-(hidroxiamino)-3-metil-1-oxobutan-2-il)-4-(((1r,2r)-2-(hidroximetil)ciclopropil)buta-1,3-dinil)benzamida
|
|
CN102603690A
(zh)
*
|
2012-01-17 |
2012-07-25 |
凯莱英医药集团（天津）股份有限公司 |
一种一锅法制备四氢吡喃-4-甲酸及其衍生物的方法
|
|
HK1201817A1
(en)
|
2012-02-17 |
2015-09-11 |
Millennium Pharmaceuticals, Inc. |
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
|
|
WO2013170030A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2847168A1
(en)
|
2012-05-10 |
2015-03-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
JP6139272B2
(ja)
*
|
2012-06-01 |
2017-05-31 |
株式会社半導体エネルギー研究所 |
発光素子の作製方法
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
WO2014165075A1
(en)
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
PT2975022T
(pt)
|
2013-03-15 |
2019-06-11 |
Fujifilm Toyama Chemical Co Ltd |
Novo derivado de ácido hidroxâmico ou um seu sal
|
|
GB201307233D0
(en)
*
|
2013-04-22 |
2013-05-29 |
Vib Vzw |
Compounds and uses thereof
|
|
BR112015032902A8
(pt)
|
2013-07-02 |
2019-12-24 |
Millennium Pharm Inc |
compostos de heteroarila, seus usos e composições farmacêuticas
|
|
US10189786B2
(en)
|
2013-08-16 |
2019-01-29 |
Duke University |
Antibacterial compounds
|
|
US9908851B2
(en)
|
2013-08-16 |
2018-03-06 |
Duke University |
2-piperidinyl substituted N,3-dihydroxybutanamides
|
|
EP3041354A4
(en)
|
2013-08-16 |
2017-06-14 |
Duke University |
Substituted hydroxamic acid compounds
|
|
US9937183B2
(en)
|
2013-09-09 |
2018-04-10 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
MX2016002975A
(es)
|
2013-09-09 |
2016-10-21 |
Melinta Therapeutics Inc |
Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
|
|
AR097617A1
(es)
|
2013-09-13 |
2016-04-06 |
Actelion Pharmaceuticals Ltd |
Derivados antibacterianos del 2h-indazol
|
|
JP2016210682A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
TW201602065A
(zh)
*
|
2013-10-18 |
2016-01-16 |
大正製藥股份有限公司 |
異羥肟酸衍生物
|
|
JP2016210683A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
ES2666130T3
(es)
|
2013-12-19 |
2018-05-03 |
Idorsia Pharmaceuticals Ltd |
Derivados antibacterianos de 1H-indazol y 1H-indol
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
WO2015173329A1
(en)
*
|
2014-05-16 |
2015-11-19 |
Actelion Pharmaceuticals Ltd |
Antibacterial quinazoline-4(3h)-one derivatives
|
|
CN106794175B
(zh)
*
|
2014-06-12 |
2020-06-09 |
西达-赛奈医疗中心 |
用于治疗癌症的组合物
|
|
HRP20191979T1
(hr)
|
2014-07-01 |
2020-02-07 |
Millennium Pharmaceuticals, Inc. |
Heteoarilni spojevi koji su korisni kao inhibitori sumo-aktivirajućeg enzima
|
|
MX2017002967A
(es)
|
2014-09-12 |
2017-05-30 |
Toyama Chemical Co Ltd |
Composicion farmaceutica novedosa que contiene derivado de acido hidroxamico o sal del mismo.
|
|
CA2960936A1
(en)
|
2014-09-12 |
2016-03-17 |
Toyama Chemical Co., Ltd. |
Method for using novel hydroxamic acid derivative and antibacterial substance in combination
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
JP6208161B2
(ja)
*
|
2015-02-06 |
2017-10-04 |
信越化学工業株式会社 |
非対称共役ジイン化合物の製造方法及びこれを用いたｚ，ｚ−共役ジエン化合物の製造方法
|
|
WO2016145417A1
(en)
|
2015-03-11 |
2016-09-15 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
US10414735B2
(en)
|
2015-11-09 |
2019-09-17 |
Forge Therapeutics, Inc. |
Substituted hydroxypyrimidinones for treating bacterial infections
|
|
US10611747B2
(en)
|
2015-11-09 |
2020-04-07 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
AU2016367510A1
(en)
*
|
2015-12-08 |
2018-06-07 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted benzazinones as antibacterial compounds
|
|
CN105669750B
(zh)
*
|
2016-03-01 |
2018-04-03 |
中国医学科学院医药生物技术研究所 |
新型锌离子螯合剂及其制备和在抗革兰氏阴性菌感染中的应用
|
|
MX2018010878A
(es)
|
2016-03-07 |
2018-11-09 |
Merck Sharp & Dohme |
Compuestos de aril-monobactam biciclicos y metodos de uso de los mismos para el tratamiento de infecciones bacterianas.
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
AU2017253625B2
(en)
*
|
2016-04-18 |
2021-08-12 |
Vivoryon Therapeutics N.V. |
Novel inhibitors of meprin alpha and beta
|
|
US11034649B2
(en)
*
|
2016-04-25 |
2021-06-15 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
JP2019515041A
(ja)
|
2016-05-06 |
2019-06-06 |
メリンタ セラピューティクス、 インコーポレイテッドＭｅｌｉｎｔａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
抗菌剤ならびにそれを作製および使用する方法
|
|
AR108864A1
(es)
|
2016-06-23 |
2018-10-03 |
Achaogen Inc |
Agentes antibacterianos
|
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THEIR THERAPEUTIC USES
|
|
US10934261B2
(en)
|
2016-09-28 |
2021-03-02 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
MX388647B
(es)
|
2016-12-23 |
2025-03-20 |
Intervet Int Bv |
Compuestos utiles para el tratamiento de una infeccion por mannheimia haemolytica o histophilus somni.
|
|
AR110440A1
(es)
|
2016-12-23 |
2019-03-27 |
Intervet Int Bv |
Compuestos para el tratamiento de la enfermedad respiratoria bovina o porcina
|
|
JP7191298B2
(ja)
|
2017-04-26 |
2022-12-19 |
バジリア・ファルマスーチカ・インターナショナル・アーゲー，アルシュヴィル |
フラザノベンズイミダゾール類及びその結晶形の調製方法
|
|
WO2018208987A2
(en)
*
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
US11351126B2
(en)
*
|
2017-07-27 |
2022-06-07 |
BioMendics, LLC |
Substituted tolans for the modulation of microbial colonization
|
|
KR20200049797A
(ko)
*
|
2017-08-21 |
2020-05-08 |
마이크로바이오틱스, 인코포레이티드 |
항균제로서 유용한 대사 안정적인 n-아실아미노옥사다이아졸
|
|
US11498909B2
(en)
|
2018-02-10 |
2022-11-15 |
Kbp Biosciences Co., Ltd. |
Compound acting as antibiotics
|
|
KR20200143376A
(ko)
|
2018-03-13 |
2020-12-23 |
샤이어 휴먼 지네틱 테라피즈 인크. |
혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도
|
|
FI3853234T3
(fi)
|
2018-09-18 |
2025-07-28 |
Nikang Therapeutics Inc |
Fuusioituja trisyklisiä rengasjohdannaisia SRC-homologia-2-fosfataasin estäjinä
|
|
AU2019345150A1
(en)
|
2018-09-20 |
2021-05-13 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|
|
JP7189369B2
(ja)
|
2018-10-30 |
2022-12-13 |
ギリアード サイエンシーズ， インコーポレイテッド |
アルファ４β７インテグリンの阻害のための化合物
|
|
JP7189368B2
(ja)
|
2018-10-30 |
2022-12-13 |
ギリアード サイエンシーズ， インコーポレイテッド |
アルファ４ベータ７インテグリンの阻害のための化合物
|
|
WO2020092394A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
|
|
CN119462635A
(zh)
|
2018-10-30 |
2025-02-18 |
吉利德科学公司 |
作为α4β7整合素抑制剂的喹啉衍生物
|
|
US20220081421A1
(en)
*
|
2018-11-14 |
2022-03-17 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
BR112021009536A2
(pt)
*
|
2018-11-21 |
2021-08-17 |
Taisho Pharmaceutical Co., Ltd. |
derivado de imidazol
|
|
KR20220047323A
(ko)
|
2019-08-14 |
2022-04-15 |
길리애드 사이언시즈, 인코포레이티드 |
알파 4 베타 7 인테그린의 저해용 화합물
|
|
CN114728962B
(zh)
|
2019-09-18 |
2025-09-19 |
武田药品工业有限公司 |
血浆激肽释放酶抑制剂及其用途
|
|
US11370803B2
(en)
|
2019-09-18 |
2022-06-28 |
Takeda Pharmaceutical Company Limited |
Heteroaryl plasma kallikrein inhibitors
|
|
CN110563611B
(zh)
*
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
WO2021138391A1
(en)
|
2019-12-30 |
2021-07-08 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
BR112022025037A2
(pt)
|
2020-06-10 |
2023-02-14 |
Aligos Therapeutics Inc |
Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus
|
|
MA63501B1
(fr)
|
2021-06-14 |
2024-07-31 |
Scorpion Therapeutics, Inc. |
Dérivés d'urée pouvant être utilisés pour traiter le cancer
|
|
AU2022306289A1
(en)
|
2021-07-09 |
2024-01-18 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
WO2023011573A1
(zh)
*
|
2021-08-05 |
2023-02-09 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和用途
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
CA3233328A1
(en)
|
2021-09-28 |
2023-04-06 |
Min Teng |
Lpxc inhibitors and uses thereof
|
|
WO2023118558A1
(en)
*
|
2021-12-24 |
2023-06-29 |
Intervet International B.V. |
Process of the preparation of hydroxylamine derivatives
|
|
WO2024067813A1
(zh)
*
|
2022-09-28 |
2024-04-04 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和其医药上的用途
|
|
CN115480037B
(zh)
*
|
2022-10-14 |
2023-07-18 |
青岛国泰检测科技有限公司 |
一种污水检测方法
|
|
CN115598253B
(zh)
*
|
2022-10-25 |
2025-02-21 |
无锡紫杉药业股份有限公司 |
一种多西他赛原料药中dcc和dcu残留的检测方法
|
|
WO2024127350A1
(en)
|
2022-12-16 |
2024-06-20 |
Astrazeneca Ab |
2,6,9-trisubstituted purines
|
|
CN117586278A
(zh)
*
|
2023-11-27 |
2024-02-23 |
华北制药集团先泰药业有限公司 |
一种氨苄西林钠杂质及其制备方法
|
|
WO2025155681A1
(en)
*
|
2024-01-19 |
2025-07-24 |
Corteva Agriscience Llc |
Nitrification inhibiting mixtures
|